Skip to main content
logo
Alnylam Pharmaceuticals, Inc. (ALNY)
NASDAQ: ALNY · Real-Time Price · USD
216.12
-12.60 (-5.51%)
At close: Aug 6, 2026, 4:00 PM EDT
218.00
+1.88 (0.87%)
After-hours: Aug 6, 2026, 7:59 PM EDT

Alnylam Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
807.99313.75-278.16-440.24-1,131-852.82
Depreciation & Amortization
54.7655.6656.6754.0544.4747.57
Stock-Based Compensation
336.62348.24272.08221.68230.65165.72
Other Adjustments
183.2251.22155.18211.4307.15160.67
Change in Receivables
-357.64-359.96-86.55-87.94-45.6-101.8
Changes in Inventories
-11.938.4713.5918.37-34.14-26.42
Changes in Accounts Payable
-65.7675.0791.0980.84191.7788.24
Changes in Unearned Revenue
-11.07-50.64-235.4555.02-65.91-50.4
Changes in Other Operating Activities
-157.42-117.723.23-9.03-38.51-72.45
Operating Cash Flow
885.89524.08-8.31104.16-541.27-641.69
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-91.95-58.7-34.28-62.21-72.06-76.37
Purchases of Investments
-1,305-1,365-1,712-1,882-2,075-1,698
Proceeds from Sale of Investments
1,5001,8621,6301,6122,3221,506
Other Investing Activities
-2.15-2.15-0.12-4.44-4.69-4.2
Investing Cash Flow
74.94436.33-116.84-336.35169.35-273.3

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
-645.69--1,016500
Long-Term Debt Repaid
-1,155--762.11-
Net Long-Term Debt Issued (Repaid)
-1,801--1,778500
Issuance of Common Stock
166.16250.03302.95147.46259.36246.27
Net Common Stock Issued (Repurchased)
166.16250.03302.95147.46259.36246.27
Other Financing Activities
68.61-46-8.7924.67-87.61500.85
Financing Cash Flow
-351.08-305.19294.16172.13425.751,247

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-16.1434.94-15.246.39-7.43-9.02
Net Cash Flow
593.62690.16153.77-53.6746.4323.11

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
793.95465.38-42.5941.95-613.33-718.07
Free Cash Flow Growth
------
FCF Margin
16.53%12.53%-1.89%2.29%-59.12%-85.05%
Free Cash Flow Per Share
5.773.46-0.330.34-5.04-6.06
Levered Free Cash Flow
524.622,026-383.3-303.2672.69-442.65
Unlevered Free Cash Flow
726.94399.12-235.52-149.51-762.35-799.05
SEC Filings: 10-K · 10-Q